← Back to Discover
Bellevue Group AG
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $4,752,644,375
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AMGEN INC · COM · 031162100 · shares: $308,363,286
- VERTEX PHARMACEUTICALS INC · COM · 92532F100 · shares: $287,424,867
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $279,258,770
- GILEAD SCIENCES INC · COM · 375558103 · shares: $272,739,254
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $196,272,062
- ORUKA THERAPEUTICS INC · COM · 687604108 · shares: $157,714,772
- INSMED INC · COM PAR $.01 · 457669307 · shares: $148,566,227
- SCHOLAR ROCK HLDG CORP · COM · 80706P103 · shares: $134,725,085
- NUVALENT INC · COM · 670703107 · shares: $130,078,598
- VIRIDIAN THERAPEUTICS INC · COM · 92790C104 · shares: $123,665,169
Reported holdings
164 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 19,007 shares | $1,619,206 |
| ALAMAR BIOSCIENCES INC | COMMON STOCK | 010911105 | — | 55,738 shares | $1,509,942 |
| PHREESIA INC | COM | 71944F106 | — | 140,495 shares | $1,445,694 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 19,376 shares | $1,443,124 |
| MOBIA MED INC | COMMON STOCK | 60705V103 | — | 100,000 shares | $1,340,000 |
| BILLIONTOONE INC | CL A | 090168105 | — | 10,554 shares | $1,266,269 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 11,678 shares | $1,245,108 |
| BETA BIONICS INC | COM | 08659B102 | — | 72,152 shares | $1,130,622 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 5,590 shares | $1,046,895 |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | — | 33,054 shares | $954,600 |
| PFIZER INC | COM | 717081103 | — | 38,431 shares | $925,418 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 6,397 shares | $852,464 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 17,902 shares | $768,175 |
| ENCOMPASS HEALTH CORP | COM | 29261A100 | — | 6,951 shares | $702,607 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 2,689 shares | $658,187 |
| CERTARA INC | COM | 15687V109 | — | 99,442 shares | $651,345 |
| AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | — | 49,248 shares | $639,239 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 1,847 shares | $618,357 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 1,530 shares | $568,655 |
| APPLE INC | COM | 037833100 | — | 1,768 shares | $540,524 |
| GARMIN LTD | SHS | H2906T109 | — | 1,976 shares | $469,379 |
| DENALI THERAPEUTICS INC | COM | 24823R105 | — | 17,766 shares | $456,942 |
| VANECK ETF TRUST | GOLD MINERS ETF | 92189F106 | — | 5,750 shares | $433,838 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 3,468 shares | $426,356 |
| ALPHABET INC | CAP STK CL A | 02079K305 | — | 907 shares | $395,609 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 8,391 shares | $394,713 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 6,908 shares | $392,443 |
| AMAZON COM INC | COM | 023135106 | — | 1,605 shares | $382,536 |
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | — | 4,348 shares | $340,318 |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | — | 1,092 shares | $328,725 |
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | — | 5,818 shares | $317,314 |
| VAXCYTE INC | COM | 92243G108 | — | 4,558 shares | $264,957 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 14,394 shares | $264,418 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 2,931 shares | $260,214 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 4,762 shares | $255,577 |
| VIATRIS INC | COM | 92556V106 | — | 15,778 shares | $250,555 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 4,515 shares | $248,325 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 8,753 shares | $236,156 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 15,279 shares | $222,615 |
| CARDINAL HEALTH INC | COM | 14149Y108 | — | 852 shares | $202,401 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 4,870 shares | $188,469 |
| TEMPUS AI INC | CL A | 88023B103 | — | 3,213 shares | $186,129 |
| REGENERON PHARMACEUTICALS | COM | 75886F107 | — | 291 shares | $181,450 |
| CENCORA INC | COM | 03073E105 | — | 576 shares | $162,996 |
| PTC THERAPEUTICS INC | COM | 69366J200 | — | 1,626 shares | $132,633 |
| CARIS LIFE SCIENCES INC | COM | 142152107 | — | 6,418 shares | $114,369 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 1,016 shares | $112,806 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 1,191 shares | $97,078 |
| NVIDIA CORPORATION | COM | 67066G104 | — | 408 shares | $81,637 |
| LABCORP HOLDINGS INC | COM SHS | 504922105 | — | 280 shares | $78,400 |
| BIOGEN INC | COM | 09062X103 | — | 338 shares | $73,028 |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | — | 1,216 shares | $70,066 |
| WATERS CORP | COM | 941848103 | — | 179 shares | $67,132 |
| MICROSOFT CORP | COM | 594918104 | — | 172 shares | $64,159 |
| IQVIA HLDGS INC | COM | 46266C105 | — | 293 shares | $56,613 |
| INCYTE CORP | COM | 45337C102 | — | 486 shares | $55,093 |
| METTLER TOLEDO INTERNATIONAL | COM | 592688105 | — | 36 shares | $45,990 |
| AGILENT TECHNOLOGIES INC | COM | 00846U101 | — | 330 shares | $43,834 |
| QUALCOMM INC | COM | 747525103 | — | 197 shares | $36,404 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 1,924 shares | $35,998 |
| ZOETIS INC | CL A | 98978V103 | — | 390 shares | $28,025 |
| ORACLE CORP | COM | 68389X105 | — | 191 shares | $27,991 |
| QUEST DIAGNOSTICS INC | COM | 74834L100 | — | 131 shares | $27,765 |
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | — | 4,627 shares | $16,981 |